BCRX vs BDX
BioCryst Pharmaceuticals, Inc. vs Becton Dickinson — AI-powered side-by-side comparison
BCRX
BioCryst Pharmaceuticals, Inc.
66
Buy
VS
BDX
Becton Dickinson
50
Watch
| Metric | BCRX | BDX |
|---|
| AI Score |
66
|
50
|
| Price |
$9.68
|
$190.62
|
| P/E Ratio |
-6.73×
|
57.45×
|
| ROE |
-221.4%
|
6.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
23.5%
|
46.1%
|
| Debt / Equity |
-0.90×
|
0.69×
|
| Dividend Yield |
0.0%
|
2.0%
|
| RSI (14) |
48.8
|
77.5
|
| Beta |
0.554
|
0.258
|
| Expected Upside |
+1.3%
|
+2.4%
|
AI Committee View
Current Innellis committee reasoning for BCRX versus BDX.
BCRX leads by 16 points.
BCRX scores 66/100 (Buy) versus BDX at 50/100 (Watch).
BCRX Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — bollinger bandwidth of 18.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Bollinger bandwidth of 18.9% signals elevated volatility — Risk
BDX Committee View
33% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Value Analyst remains cautious — p/e of 53.2 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 53.2 is expensive by classic value standards — Value
- ROE of only 3.8% -- cheap may mean cheap for a reason — Value
- Revenue declining -2.6% YoY -- this is not a growth story right now — Growth